JHVEPhoto
Thermo Fisher Scientific (NYSE:TMO) is looking to sell some of its lower-growth diagnostic assets for around $4B, the Financial Times reported, citing three people familiar with the matter.
The company's advisers approached private equity firms in recent weeks to gauge